PL170920B1 - Sposób wytwarzania nowych pochodnych izatynoksymu PL PL PL - Google Patents

Sposób wytwarzania nowych pochodnych izatynoksymu PL PL PL

Info

Publication number
PL170920B1
PL170920B1 PL92302584A PL30258492A PL170920B1 PL 170920 B1 PL170920 B1 PL 170920B1 PL 92302584 A PL92302584 A PL 92302584A PL 30258492 A PL30258492 A PL 30258492A PL 170920 B1 PL170920 B1 PL 170920B1
Authority
PL
Poland
Prior art keywords
branched
hydrogen
cyclic
compound
substituents
Prior art date
Application number
PL92302584A
Other languages
English (en)
Polish (pl)
Inventor
Frank Watjen
Bjarne H Dahl
Jorgen Drejer
Leif H Jensen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of PL170920B1 publication Critical patent/PL170920B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL92302584A 1991-08-28 1992-08-27 Sposób wytwarzania nowych pochodnych izatynoksymu PL PL PL PL170920B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75116591A 1991-08-28 1991-08-28
US83185192A 1992-02-05 1992-02-05
PCT/EP1992/001999 WO1993005043A1 (en) 1991-08-28 1992-08-27 Novel isatinoxime derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
PL170920B1 true PL170920B1 (pl) 1997-02-28

Family

ID=27115380

Family Applications (1)

Application Number Title Priority Date Filing Date
PL92302584A PL170920B1 (pl) 1991-08-28 1992-08-27 Sposób wytwarzania nowych pochodnych izatynoksymu PL PL PL

Country Status (18)

Country Link
EP (1) EP0529636B1 (enExample)
JP (1) JP3170584B2 (enExample)
KR (1) KR100277481B1 (enExample)
AT (1) ATE181552T1 (enExample)
AU (1) AU655672B2 (enExample)
CA (1) CA2076948C (enExample)
CZ (1) CZ282759B6 (enExample)
DE (1) DE69229461T2 (enExample)
DK (1) DK0529636T3 (enExample)
FI (1) FI107156B (enExample)
GE (1) GEP20002329B (enExample)
HU (2) HUT70753A (enExample)
MX (1) MX9204914A (enExample)
NO (1) NO301117B1 (enExample)
PL (1) PL170920B1 (enExample)
RU (1) RU2114827C1 (enExample)
SK (1) SK280578B6 (enExample)
WO (1) WO1993005043A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08502483A (ja) 1992-10-13 1996-03-19 ワーナー−ランバート・コンパニー 新規なキノキサリンジオン誘導体、それらの製造および使用
US5843945A (en) * 1993-05-13 1998-12-01 Neurosearch A/S AMPA antagonists and a method of treatment
FI954965L (fi) * 1993-05-13 1995-11-10 Neurosearch As AMPA-antagonisteja ja hoitomenetelmä, jossa niitä käytetään
DK81593D0 (da) * 1993-07-07 1993-07-07 Neurosearch As Nye isatinoximderivater, deres fremstilling og anvendelse
EP0781285B1 (en) * 1994-09-14 2000-01-12 Neurosearch A/S Fused indole and quinoxaline derivatives, their preparation and use as glutamate antagonists
CA2199613C (en) * 1994-09-14 2000-02-29 Peter Moldt Indole-2,3-dione-3-oxime derivatives, their preparation and use
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
FR2768624B1 (fr) * 1997-09-25 1999-11-12 Oreal Utilisation d'un inhibiteur d'acides amines excitateurs dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
DE60041399D1 (de) 1999-05-19 2009-03-05 Painceptor Pharma Corp Hemmer der protonenabhängigen kationenkanäle und deren verwendung in der behandlung von ischemiebedingten erkrankungen
EP1736468A3 (en) 2000-01-24 2007-01-03 NeuroSearch A/S Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation
WO2004039372A1 (en) 2002-10-29 2004-05-13 Sungkyunkwan University Medicament component of berberine for the use of prevention and treatment of psycological dependence on and analgesic tolerance to morphine
EP1957486A4 (en) 2005-11-23 2009-11-11 Painceptor Pharma Corp COMPOSITIONS AND METHODS FOR MODULATION OF IONIC CHANNELS
WO2014095675A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic-indanyl carboxamides as fungicides
US9815768B2 (en) * 2014-02-28 2017-11-14 Sumitomo Chemical Company, Limited Method for producing 2-(halogenomethyl)-3-methylnitrobenzene
HUE055651T2 (hu) 2016-03-17 2021-12-28 Fmc Corp Eljárás S-enantiomer konvertálására racém formájává
CN112266368B (zh) * 2017-11-15 2024-03-19 中山光禾医疗科技有限公司 光交联水凝胶材料的制备、原料、产品及应用
CN108912127B (zh) * 2018-08-27 2019-12-10 青岛农业大学 一种基于靛红骨架的苯并[b,e]氮杂卓化合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69677B1 (en) * 1989-12-11 1996-10-02 Neurosearch As Isatine derivatives their preparation and use

Also Published As

Publication number Publication date
WO1993005043A1 (en) 1993-03-18
AU655672B2 (en) 1995-01-05
FI107156B (fi) 2001-06-15
EP0529636A1 (en) 1993-03-03
FI940889A7 (fi) 1994-02-25
CZ39594A3 (en) 1994-11-16
NO940676D0 (no) 1994-02-25
SK23894A3 (en) 1994-12-07
NO301117B1 (no) 1997-09-15
MX9204914A (es) 1993-07-01
GEP20002329B (en) 2000-12-25
HU9400595D0 (en) 1994-05-30
DE69229461T2 (de) 1999-10-21
SK280578B6 (sk) 2000-04-10
JPH06510056A (ja) 1994-11-10
NO940676L (enExample) 1994-04-27
DK0529636T3 (da) 1999-12-13
RU2114827C1 (ru) 1998-07-10
CA2076948C (en) 2002-04-16
HUT70753A (en) 1995-10-30
FI940889A0 (fi) 1994-02-25
DE69229461D1 (de) 1999-07-29
HU211632A9 (en) 1995-12-28
AU2482092A (en) 1993-04-05
ATE181552T1 (de) 1999-07-15
JP3170584B2 (ja) 2001-05-28
CA2076948A1 (en) 1993-03-01
EP0529636B1 (en) 1999-06-23
CZ282759B6 (cs) 1997-09-17
KR100277481B1 (ko) 2001-02-01

Similar Documents

Publication Publication Date Title
PL170920B1 (pl) Sposób wytwarzania nowych pochodnych izatynoksymu PL PL PL
FI86727B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-fenyl- eller halogenfenyl-7,8,9,10 -tetrahydropyrido/e//1,2,4/triazolo/1,5-c/-pyrimidoner.
EP0503349B1 (en) Hydrazone derivatives, their preparation and use
JPS62108882A (ja) N−置換−N−〔3−(1,2,4−トリアゾロ〔4,3−b〕ピリダジン−6−イル)フエニル〕アルカンアミド類、カルバメ−ト類及びウレア類
CA2238410C (en) Novel indole-2,3-dione-3-oxime derivatives
CA2142721A1 (en) Condensed indole derivatives as 5ht and 5ht antagonists
HU187913B (en) Process for producing alkyl-imidazo-bracket-1,2-c-bracket closed pyrazolo-bracket-3,4-e-bracket closed-pyrimidine derivatives and antipsychotic compositions containing them
Huff et al. Bioactive conformation of 1-arylpiperazines at central serotonin receptors
JP3010558B2 (ja) 新規の1,7‐融合1h‐インドール‐2‐カルボン酸‐n‐(1,4‐ベンゾジアゼピン‐3‐イル)‐アミド、その製法及びこれを含有するコレシストキニン拮抗作用薬剤
EP1066037B1 (en) Use of indole-2,3-dione-3-oxime derivatives as ampa antagonists
CA2612109A1 (en) Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists
Hester Jr et al. Pyrrolo [3, 2, 1-jk][1, 4] benzodiazepines and pyrrolo [1, 2, 3-ef][1, 5] benzodiazepines which have central nervous system activity
PT87160B (pt) Processo para a preparacao de 3h-1,2,3-triazolo{4,5-d}pirimidinas
CZ290678B6 (cs) 3-Substituované 3,4,5,7-tetrahydropyrrolo[3´,4´: 4,5]thieno[2,3-d]pyrimidinové deriváty, způsob jejich přípravy a použití
JP2582799B2 (ja) 置換ヘキサヒドロアリ−ルキノリジン類
US5436250A (en) Isatineoxime derivatives, their preparation and use
US5242918A (en) Isatinoxime derivatives, their preparation and use
JPH09508637A (ja) 5ht2bレセプタ拮抗薬縮合インドール
FI88036C (fi) Foerfarande foer framstaellning av saosom bensodiazepinreceptoragonister/antagonister anvaendbara 2-aryl-tetrahydro(pyrido- och pyrrolo)/e//1,2,4/triazolo/1,5-c/pyrimidoner